Side effects of taking melatonin for More than 4 months daily
Reading File
Searching PubMed
melatonin long-term daily use side effects
Searching the Web
melatonin daily use more than 4 months side effects long-term safety
Finding Sources
Searching PubMed
melatonin chronic use hormonal endocrine effects safety
Reading File
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC10053496
Here is a thorough breakdown of what the evidence says about taking melatonin daily for more than 4 months:
Side Effects of Long-Term Daily Melatonin Use (4+ Months)
Important Context First
The short answer is: long-term melatonin use is understudied. Most research covers 1-3 months of use. What we do know comes from a mix of clinical trials, observational studies, and case reports. Low doses (0.5-5 mg/day) appear relatively safe for most people, but several specific concerns have emerged for extended use.
1. Persistent Common Side Effects
These are present with any use and may continue throughout long-term use:
- Daytime drowsiness/somnolence - the most frequently reported effect
- Headache - commonly reported, though some placebo-controlled trials found no significant difference vs. placebo
- Dizziness
- Irritability and mood changes
- Vivid dreams or nightmares
- Nausea and GI upset
(Tintinalli's Emergency Medicine; PMC10053496)
2. Hormonal and Reproductive Concerns
Melatonin receptors (MT2) are found in the pituitary pars tuberalis and are directly involved in reproductive signaling. Prolonged high-dose use raises concerns about:
- Suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) - potentially affecting fertility in both men and women
- Menstrual cycle irregularities in women
- Effects on pubertal development in children and adolescents (an active area of concern in pediatric prescribing)
These effects are dose-dependent and more concerning at pharmacological doses (>5 mg/day).
3. Bone Fracture Risk (Older Adults)
A UK study found that adults (average age 65) who received 3 or more melatonin prescriptions (2 mg extended-release) were 44% more likely to suffer a fracture than controls. The mechanism is not fully established - it may relate to balance impairment and falls, or possibly direct effects on bone metabolism. This is a reason for caution in older adults and those with a prior low-impact fracture history. (PMC10053496)
4. Cardiovascular Signal (Preliminary)
A 2025 AHA Scientific Sessions abstract found a ~90% increase in heart failure risk in people with chronic insomnia who took melatonin for 5 or more years, compared to insomnia patients who did not take it. However:
- This was a retrospective, preliminary study - not a confirmed causal relationship
- Confounding factors (e.g., underlying cardiovascular risk in the insomnia group) were not fully controlled
- Northwestern Medicine cardiologist Dr. Micah Eimer noted that a prospective trial is needed before any firm conclusions
This finding should not cause panic, but it is worth discussing with a physician if you are at cardiac risk.
5. Potential Drug Interactions (Compounds with Chronic Use)
With extended use, cumulative drug interactions become more relevant:
- Blood thinners (warfarin, aspirin, NSAIDs) - melatonin may increase bleeding risk
- Beta-blockers - may reduce endogenous melatonin production; interaction is complex
- Antidepressants and SSRIs - potential serotonergic interaction
- Immunosuppressants - melatonin has immunomodulatory effects; may interfere
- CYP1A2-metabolized drugs - melatonin is metabolized via CYP1A2; drugs using the same pathway may have altered levels
6. Cognitive and Balance Effects
Some studies noted impairment of balance and cognition, especially in older adults, with daily use. This is primarily a fall/injury risk concern rather than a permanent cognitive change.
7. Does Melatonin Suppress Natural Secretion?
A common worry is that taking exogenous melatonin will cause the pineal gland to "shut down" its own production (similar to how testosterone supplementation suppresses the HPG axis). Current evidence suggests this does not appear to occur at standard doses - no confirmed suppression of endogenous melatonin production has been consistently demonstrated. (Kosinska Medical Journal review)
8. Worsening of Psychiatric Conditions
At very high doses (250-1200 mg/day), worsening of depression and bipolar disorder has been reported. At standard doses (0.5-6 mg/day), a study following patients for up to 3.5 years found no worsening of depression. (PMC10053496)
Summary Table
| Side Effect | Evidence Strength | Dose Dependence |
|---|---|---|
| Daytime drowsiness, headache | Strong | Low-moderate |
| Vivid dreams, irritability | Moderate | Moderate |
| Bone fracture risk | Moderate (observational) | Higher doses / older adults |
| Hormonal/reproductive disruption | Moderate | Higher doses |
| Cardiovascular (heart failure) | Preliminary (2025 abstract) | Long-term (5+ years) |
| Balance/cognition impairment | Moderate | Older adults |
| Worsening mood disorders | Low at standard doses | Very high doses mainly |
| Endogenous suppression | Not confirmed | Unlikely at standard doses |
Practical Advice
- Most guidelines recommend melatonin for 1-2 months, then reassessing sleep without it
- If you are using it beyond 4 months, a dose of 0.5-3 mg (the lowest effective dose) is preferred over higher doses
- If you are over 65, have cardiac risk factors, take blood thinners, or have a mood disorder, speak with your doctor before continuing
- The UC Davis Health overview and the PMC full review (PMC10053496) are good readable references for further reading
This is a shared conversation. Sign in to Orris to start your own chat.